scholarly article | Q13442814 |
P356 | DOI | 10.1056/NEJM198010303031807 |
P698 | PubMed publication ID | 7421893 |
P50 | author | David W Kaufman | Q40570417 |
Lynn Rosenberg | Q55454936 | ||
P2093 | author name string | S Shapiro | |
D Slone | |||
J L Lewis | |||
P D Stolley | |||
O S Miettinen | |||
D Schottenfeld | |||
N B Rosenshein | |||
R L Engle | |||
R C Knapp | |||
T Leavitt | |||
W G Watring | |||
P433 | issue | 18 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endometrial cancer | Q944777 |
P304 | page(s) | 1045-1047 | |
P577 | publication date | 1980-10-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | Decreased risk of endometrial cancer among oral-contraceptive users | |
P478 | volume | 303 |
Q37304563 | A case-control study of oral contraceptive use and incident breast cancer |
Q71100414 | Assessment of oestrogen and progestin effects on epithelium and stroma from pre- and postmenopausal endometria |
Q72564753 | Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use |
Q37661580 | Catch it before it kills: progesterone, obesity, and the prevention of endometrial cancer |
Q49158376 | Current status of estrogen therapy for the menopause |
Q40167813 | Do hormones cause breast cancer? |
Q30049057 | Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies |
Q43494603 | Endometrial cancer in Olmsted County, MN: trends in incidence, risk factors and survival |
Q44867606 | Endometrial histology during use of a low-dose estrogen-desogestrel oral contraceptive with a reduced hormone-free interval |
Q37041231 | Endometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapy |
Q38788210 | Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences |
Q35443242 | Epidemiology of the noncontraceptive effects of oral contraceptives |
Q37809855 | Estrogen-Free Oral Hormonal Contraception: Benefits of the Progestin-Only Pill |
Q60728526 | Exogenous Hormone Use and Endometrial Cancer in U.S. Black Women |
Q70369336 | Exogenous hormones in the aetiology of cancer in women |
Q34834274 | Hormones and breast and endometrial cancers: preventive strategies and future research |
Q40339592 | Noncontraceptive health benefits of oral steroidal contraceptives. |
Q35976772 | Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism |
Q39676752 | On the epidemiology of oral contraceptives and disease |
Q38904650 | Oral contraceptive use and malignancies of the genital tract. Results from the Royal College of General Practitioners' Oral Contraception Study |
Q36027496 | Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study |
Q39764556 | Oral contraceptives and neoplasia: 1987 update. |
Q57562355 | Oral contraceptives and the risk of endometrial cancer |
Q72750537 | Oral contraceptives containing chlormadinone acetate and cancer incidence at selected sites in the German Democratic Republic - A correlation analysis |
Q72130727 | Recency, duration, and progestin content of oral contraceptives in relation to the incidence of endometrial cancer (Washington, USA) |
Q68850370 | Recent time trends in uterine cancer |
Q46094504 | Risk factors of female cancers in Ragusa population (Sicily)--1. Endometrium and cervix uteri cancers |
Q68319409 | Safety of depot medroxyprogesterone acetate |
Q42334969 | Sex hormones and gynaecological cancer |
Q30658394 | Signal generation and clarification: use of case-control data. |
Q73937722 | Strategies to reduce the incidence of endometrial cancer in postmenopausal women |
Q36047673 | The epidemiology of endometrial cancer in young women |
Q24610937 | The progesterone receptor gene maps to human chromosome band 11q13, the site of the mammary oncogene int-2 |
Q38031401 | The relationship between oral contraceptive use, cancer and vascular disease |
Q34690392 | Understanding obesity and endometrial cancer risk: opportunities for prevention |
Search more.